Loading...

LTRN LANTERN PHARMA INC Investments/Divestments 8-K Filing

LNTR

LTRN

LANTERN PHARMA INC

(LTRN)

2023 8-K

Show Summary

Show Summary

Equity Offerings

Financial Statements

Financial Results

Management Changes

Q3 Results Call

Q3 Earnings Announcement

Annual Meeting of Stockholders

By-laws Amendment

Earnings Reports

Earnings Reports

Management Changes

Investment Agreement

Death of Director

Earnings Reports

Annual Meeting of Stockholders

Earnings Reports

Earnings Reports

Salary Increase

External Links:

Lantern Pharma Inc. entered into Securities Purchase Agreements to purchase 145,348 shares of company common stock from Bios Fund I QP, LP and Bios Fund I, LP for a total purchase price of $499,997.12.

AI Assistant

LANTERN PHARMA INC

2023

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.